Dyax Corp. buy klostergang
Start price
18.06.15
/
50%
€21.87
Target price
27.01.16
€28.00
Performance (%)
63.96%
End price
27.01.16
€35.86
Summary
This prediction ended on 27.01.16 with a price of €35.86. The BUY prediction by klostergang for Dyax Corp. saw massive gains of 63.96%. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Dyax Corp. | - | - | - | - |
| iShares Core DAX® | 0.224% | 2.031% | 21.399% | 71.886% |
| iShares Nasdaq 100 | 0.371% | -0.955% | 5.637% | 113.046% |
| iShares Nikkei 225® | 0.972% | -0.953% | 13.432% | 47.267% |
| iShares S&P 500 | 0.417% | -0.622% | 3.310% | 68.687% |
Comments by klostergang for this prediction
In the thread Dyax Corp. diskutieren
Could be a juicy acquisition :
Dyax Corp is abiopharmaceutical company focused onHereditary Angioedema and Other Plasma-Kallikrein-Mediated (PKM)Disorders andLicensing and Funded Research Portfolio.
(Vom Mitglied beendet)


